| C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites JC Chambers, S Eda, P Bassett, Y Karim, SG Thompson, JR Gallimore, ... Circulation 104 (2), 145-150, 2001 | 616 | 2001 |
| Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis P Alba, L Bento, MJ Cuadrado, Y Karim, MF Tungekar, I Abbs, ... Annals of the rheumatic diseases 62 (6), 556-560, 2003 | 315 | 2003 |
| Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents MY Karim, P Alba, MJ Cuadrado, IC Abbs, DP D'Cruz, MA Khamashta, ... Rheumatology 41 (8), 876-882, 2002 | 231 | 2002 |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort SE Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D Nature 583 (7814), 90-95, 2020 | 211 | 2020 |
| Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus MY Karim, LC Miranda, CM Tench, PA Gordon, DP D'cruz, MA Khamashta, ... Seminars in arthritis and rheumatism 31 (5), 289-298, 2002 | 155 | 2002 |
| Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients. CN Pisoni, FJ Sanchez, Y Karim, MJ Cuadrado, DP D'Cruz, IC Abbs, ... The Journal of rheumatology 32 (6), 1047-1052, 2005 | 140 | 2005 |
| Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension SR Sangle, DP D’Cruz, W Jan, MY Karim, MA Khamashta, IC Abbs, ... Annals of the rheumatic diseases 62 (10), 999-1002, 2003 | 137 | 2003 |
| Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations T Lorenzini, M Fliegauf, N Klammer, N Frede, M Proietti, A Bulashevska, ... Journal of Allergy and Clinical Immunology 146 (4), 901-911, 2020 | 120 | 2020 |
| Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome P Alba, MY Karim, BJ Hunt Lupus 12 (8), 633-635, 2003 | 113 | 2003 |
| Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens MJ Cuadrado, Y Karim, G Sanna, E Smith, MA Khamashta, GRV Hughes The American journal of medicine 118 (3), 246-250, 2005 | 104 | 2005 |
| Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers S Sciascia, L Ceberio, C Garcia-Fernandez, D Roccatello, Y Karim, ... Autoimmunity reviews 12 (2), 157-163, 2012 | 96 | 2012 |
| Mycophenolate mofetil and systemic lupus erythematosus: an overview CN Pisoni, Y Karim, MJ Cuadrado Lupus 14 (3_suppl), 9-11, 2005 | 81 | 2005 |
| The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis Z Adhya, S Borozdenkova, MY Karim Nephrology Dialysis Transplantation 26 (10), 3273-3280, 2011 | 76 | 2011 |
| Normal complement C4 values do not exclude hereditary angioedema Y Karim, H Griffiths, S Deacock Journal of Clinical Pathology 57 (2), 213-214, 2004 | 76 | 2004 |
| Update on immunotherapy for systemic lupus erythematosus—what's hot and what's not! MY Karim, CN Pisoni, MA Khamashta Rheumatology 48 (4), 332-341, 2009 | 75 | 2009 |
| Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy MY Karim, CN Pisoni, L Ferro, MF Tungekar, IC Abbs, DP D'Cruz, ... Rheumatology 44 (10), 1317-1321, 2005 | 73 | 2005 |
| Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema MY Karim, A Masood Journal of allergy and clinical immunology 109 (2), 370-371, 2002 | 72 | 2002 |
| The role of immune complexes in atherogenesis DFP Burut, Y Karim, GAA Ferns Angiology 61 (7), 679-689, 2010 | 70 | 2010 |
| Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. CN Pisoni, G Obermoser, MJ Cuadrado, FJ Sanchez, Y Karim, NT Sepp, ... Clinical and experimental rheumatology 23 (3), 393-396, 2005 | 69 | 2005 |
| Management of infection in systemic lupus erythematosus S Sciascia, MJ Cuadrado, MY Karim Best Practice & Research Clinical Rheumatology 27 (3), 377-389, 2013 | 59 | 2013 |
